2017
DOI: 10.1038/ncomms14366
|View full text |Cite
|
Sign up to set email alerts
|

Dosage sensitivity is a major determinant of human copy number variant pathogenicity

Abstract: Human copy number variants (CNVs) account for genome variation an order of magnitude larger than single-nucleotide polymorphisms. Although much of this variation has no phenotypic consequences, some variants have been associated with disease, in particular neurodevelopmental disorders. Pathogenic CNVs are typically very large and contain multiple genes, and understanding the cause of the pathogenicity remains a major challenge. Here we show that pathogenic CNVs are significantly enriched for genes involved in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
127
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 127 publications
(135 citation statements)
references
References 66 publications
8
127
0
Order By: Relevance
“…For example, Makino et al highlighted the importance of cross-species SV deserts in identifying disease-related SVs in humans (Makino et al 2013). Rice and McLysaght, as well as Makino et al used conservation, both at the sequence and copy number levels, as a proxy to show that SV pathogenicity can be predicted by dosage sensitivity (Rice and McLysaght 2017). In sum, by constructing an updated map of SV hotspots, and outlining their broad evolutionary implications, our study opens new avenues for research to better understand genome evolution and biomedical implications of complex variations.…”
Section: A Note On Background Selection and Svsmentioning
confidence: 82%
“…For example, Makino et al highlighted the importance of cross-species SV deserts in identifying disease-related SVs in humans (Makino et al 2013). Rice and McLysaght, as well as Makino et al used conservation, both at the sequence and copy number levels, as a proxy to show that SV pathogenicity can be predicted by dosage sensitivity (Rice and McLysaght 2017). In sum, by constructing an updated map of SV hotspots, and outlining their broad evolutionary implications, our study opens new avenues for research to better understand genome evolution and biomedical implications of complex variations.…”
Section: A Note On Background Selection and Svsmentioning
confidence: 82%
“…Since the vast majority of CNVs are unique and nonrecurrent, determining the clinical significance can be challenging . Benign CNVs are often small, intergenic, or encompass genes that can tolerate a change in copy number, whereas pathogenic CNVs are significantly enriched for genes involved in development and genes with constrained evolutionary patterns of duplication and loss . Professional guidelines have been developed for the interpretation and reporting of clinically relevant CNVs, and consider factors such as size (albeit with caution), genomic content, comparison with internal and external databases for population frequency information, and whether the CNV is inherited or de novo …”
Section: Clinical Significance Of Cnvsmentioning
confidence: 99%
“…10,11 Benign CNVs are often small, intergenic, or encompass genes that can tolerate a change in copy number, whereas pathogenic CNVs are significantly enriched for genes involved in development and genes with constrained evolutionary patterns of duplication and loss. 12 Professional guidelines have been developed for the interpretation and reporting of clinically relevant CNVs, and consider factors such as size (albeit with caution), genomic content, comparison with internal and external databases for population frequency information, and whether the CNV is inherited or de novo. 13 Chromosomal microarray (CMA) has been advocated as a firsttier cytogenetic diagnostic test for patients with unexplained developmental delay/ intellectual disability, autism spectrum disorders, or multiple congenital anomalies.…”
Section: Clinical Significance Of Cnvsmentioning
confidence: 99%
“…gene dosage-effect;Desjardin et al, 2012. Although the alteration of gene-dosage balance is often prejudicial to fitness and have been mostly documented with diseases(Gamazon & Stranger 2015;Rice & McLysaght., 2017), in some cases, gene dosage-effect induce by CNVs can be positive and facilitate the adaptation of organisms to environmental changes. For example, CNVs have been highlighted as drivers of insecticide resistance in populations of Aedes mosquitoes by increasing the effectiveness of detoxification enzymes…”
mentioning
confidence: 99%